References
- UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [UK Prospective Diabetes Study Group]. Lancet 1998;352:837–53
- Porte Jr D, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 2001;50(Suppl 1): S160–S163
- Riddle M. Timely addition of insulin to oral therapy for Type 2 diabetes. Diabetes Care 2002;25:395–6
- Yki-Järvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes [HOE 901/3002 Study Group]. Diabetes Care 2000;23: 1130–6
- Massi Benedetti M, Humburg E, Dressler A, et al. A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with Type 2 diabetes. Horm Metab Res 2003;35:189–96
- Yki-Järvinen H, Kauppila M, Kujansuu E, et al. Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. New Engl J Med 1992;327:1426–33
- Rosenstock J, Schwartz S, Clark CJ, et al. Basal insulin therapy in Type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 2001;24:631–6
- Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 2002;26:S18–S24
- Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 2002;45:937–48
- Heinemann L, Linkeschova R, Rave K, et al. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000;23:644–9
- Bolli GB, Di Marchi RD, Park GD, et al. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 1999;42:1151–67
- Mudaliar S, Edelman SV. Insulin therapy in Type 2 diabetes. Endocrinol Metab Clin North Am 2001;30:935–82
- Brown J, Harris SB, Webster-Bogaert S, et al. The role of patient, physician and systemic factors in the management of Type 2 diabetes mellitus. Fam Pract 2002;19: 344–9
- Rubin R, Peyrot M, Saudek CD. Effect of diabetes education on self-care, metabolic control, and emotional well-being. Diabetes Care 1989;12:673–9
- Graziani C, Rosenthal M, Diamond J. Diabetes education program use and patient-perceived barriers to attendance. Fam Med 1999;31:358–63
- Tankova T, Dakovska G, Koev D. Education of diabetic patients – a one year experience. Patient Educ Couns 2001;43: 139–45
- Matteucci E, Giampietro O. Closing the gap between literature and practice: evaluation of a teaching programme (in the absence of a structured treatment) on both Type 1 and Type 2 diabetes. Diabetes Nutr Metab 2003;16:298–305
- de Sonnaville JJ, Bouma M, Colly LP, et al. Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study. Diabetologia 1997;40:1334–40
- Sarkadi A, Rosenqvist U. Experience-based group education in Type 2 diabetes: a randomised controlled trial. Patient Educ Couns 2004;53:291–8
- Riddle M, Rosenstock J, Gerich J. Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of Type 2 diabetes patients. Diabetes Care 2003;26: 3080–6
- Riddle M, Stewart J, Bradley C. The treat-to-target trial: randomized addition of insulin to oral therapy of Type 2 diabetes. Diabetologia 2000;43: 3080–6
- Sinha AFC, Tsalamandris C, Panagiotopoulos S, et al. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabet Med 1996; 13:40–6
- DCCT. Influence of intensive diabetes treatment on body weight and composition of adults with Type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 2001;24:1711–21
- Schreiber SA, MD, Russann A. Insulin glargine and educational intervention in patients with Type 2 diabetes in clinical practice: long-term improvement in glycaemic control without weight gain. Exp Clin Endocrinol Diabetes 2006:114:in press